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Background:  Autophagy (the cellular process responsible for the degradation and recycling of damaged proteins and organelles) is 
a downstream pathway which plays a role in decreasing ischemia-reperfusion (I-R) injury. We have previously demonstrated that the 
agonism of the Sphingosine-1 phosphate receptor (S1P-R) protects against myocardial I-R injury. We postulated that the beneficial effects 
of S1P-R agonism against I-R injury are mediated by activation of cardiomyocyte authophagy.
methods:  S1P-R agonism was induced by treatment with Fingolimod (FIN, the only FDA-approved S1P-R agonist for clinical use). Human 
AC16 cardiomyocyte were subjected to hypoxia/reoxigenation. Cell survival, apoptosis, and activation of the autophagy pathway were 
studied in vitro. Acute MI was induced in 15 pigs by 60-min balloon occlusion of LAD, followed by reperfusion. Animals randomly received 
FIN 15 minute pre-reperfusion, or saline for controls. One day post-MI, animals were evaluated with 3Dechocardiography and sacrificed. MI 
size was assessed with TTC staining and autophagy was evaluated in the myocardial border ischemic area.
results:  In vitro, FIN increased cell viability, reduced apoptosis (flow cytometry for annexin-V and WB for caspase-3), and induced 
autophagy (WB for ATG5, LC-II, and IH for LC-II). In vivo, S1P-R activation with FIN resulted in upregulation of autophagy (by electron 
microscopy for autophagosomes, IH for LC-II, and WB for ULK-1, beclin, ATG4, ATG5, LC-II, p62). Besides, FIN-treated pigs showed 
lower MI size by TTC, better LVEF, and more preserved 3D-strains. These beneficial properties of FIN were at least partially mediated by 
induction of autophagy because pharmacological inhibition of autophagy with chloroquine prevented FIN-induced cardioprotective actions 
both in vivo and in vitro.
conclusion:  Early S1P-R activation by FIN before reperfusion significantly reduced MI size and improved systolic LV function by activating 
cardiomyocyte autophagy in the ischemic area. These data support a cardioprotective role for S1P-R agonism during myocardial ischemia.
